1.
A Meta-Analysis of Intravitreal Ranibizumab versus Laser Photocoagulation for the Treatment of Retinopathy of Prematurity.
Baiad Abed A, Sun Catherine, Yin Grace S, Popovic Marko M, Muni Rajeev H, Mireskandari Kamiar et al.
Ophthalmol RetinaJan 20250 citationsMeta-Analysis
This meta-analysis compared intravitreal ranibizumab (IVR) to laser for retinopathy of prematurity (ROP). IVR showed similar disease regression but required more additional treatment, yet resulted in less myopia, impacting long-term visual outcomes.